These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10068114)

  • 41. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysplastic hepatic nodules: radiological abnormalities and histopathological correlations.
    Ouedraogo NA; Danjoux-de-Volontat M; Auriol J; Peron JM; Rousseau H; Otal P
    Eur J Radiol; 2011 Aug; 79(2):232-6. PubMed ID: 20675086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas.
    Mion F; Grozel L; Boillot O; Paliard P; Berger F
    Gastroenterology; 1996 Dec; 111(6):1587-92. PubMed ID: 8942738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Association of cirrhosis and hepatocellular carcinoma with porphyria cutanea tarda].
    Ishibashi H; Matsunaga T; Dohmen K
    Nihon Rinsho; 1995 Jun; 53(6):1474-8. PubMed ID: 7616664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions.
    Terada T; Nakanuma Y
    Arch Pathol Lab Med; 1989 Aug; 113(8):916-20. PubMed ID: 2757493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.
    Le Bail B; Bernard PH; Carles J; Balabaud C; Bioulac-Sage P
    J Hepatol; 1997 Nov; 27(5):835-42. PubMed ID: 9382971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
    Hussain SM; Zondervan PE; IJzermans JN; Schalm SW; de Man RA; Krestin GP
    Radiographics; 2002; 22(5):1023-36; discussion 1037-9. PubMed ID: 12235331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies.
    Terada T; Kadoya M; Nakanuma Y; Matsui O
    Cancer; 1990 May; 65(9):1994-2000. PubMed ID: 1695543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Case Report of Hepatocellular Carcinoma in a Non-cirrhotic Patient With Liver Iron Overload Associated With Myelodysplastic Syndrome.
    Ikoma N; Shinozaki H; Kozuki A; Ibuki S; Sugano K; Mukai M; Masuda Y; Kobayashi K; Ogata Y
    World J Oncol; 2013 Dec; 4(6):248-251. PubMed ID: 29147365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
    Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A
    Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver precancerous lesions and hepatocellular carcinoma: the histology report.
    Roncalli M; Terracciano L; Di Tommaso L; David E; Colombo M; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A histopathologic study of early hepatocellular carcinoma.
    Kondo Y; Niwa Y; Akikusa B; Takazawa H; Okabayashi A
    Cancer; 1983 Aug; 52(4):687-92. PubMed ID: 6305484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocarcinogenesis: imaging-pathologic correlation.
    Park YN; Kim MJ
    Abdom Imaging; 2011 Jun; 36(3):232-43. PubMed ID: 21267560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iron overload without the C282Y mutation in patients with epilepsy.
    Ikeda M
    J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):551-3. PubMed ID: 11254788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child.
    Theise ND
    Gastroenterology; 1996 Aug; 111(2):526-8. PubMed ID: 8690221
    [No Abstract]   [Full Text] [Related]  

  • 59. Minute scirrhous hepatocellular carcinomas undergoing different carcinogenetic processes.
    Fujii T; Zen Y; Nakanuma Y
    Pathol Int; 2007 Jul; 57(7):443-8. PubMed ID: 17587244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.
    Deguti MM; Sipahi AM; Gayotto LC; Palácios SA; Bittencourt PL; Goldberg AC; Laudanna AA; Carrilho FJ; Cançado EL
    Braz J Med Biol Res; 2003 Jun; 36(6):739-45. PubMed ID: 12792703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.